SCHEMBL20633732

SCHEMBL20633732

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2nc(-c3ccc4c(c3)oc3ccccc34)nc(-n3c4ccccc4c4cc(-c5ccccc5)ccc43)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
PLA2G2A P14555 3/20 0.38
PLA2G4A P47712 3/20 0.38
HCRTR1 O43613 1/20 0.37
AHR P35869 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
TSPO P30536 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
CHEK2 O96017 1/20 0.34
TTR P02766 1/20 0.34
PLA2G10 O15496 1/20 0.34
PRKDC P78527 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20633801 1.00 MMP12 (0.38) MMP12MMP13PLA2G2APLA2G4AHCRTR1
SCHEMBL24303213 0.96 MMP12 (0.38) MMP12MMP13PLA2G2APLA2G4AHCRTR1
SCHEMBL30021819 0.96 MMP12 (0.38) MMP12MMP13PLA2G2APLA2G4AHCRTR1
SCHEMBL21128770 0.96 MMP12 (0.38) MMP12MMP13PLA2G2APLA2G4AHCRTR1
SCHEMBL22960516 0.95 HCRTR1 (0.37) MMP12MMP13PLA2G2APLA2G4AHCRTR1
SCHEMBL22737863 0.94 PLA2G2A (0.38) MMP12MMP13PLA2G2APLA2G4AHCRTR1
SCHEMBL24303202 0.94 PLA2G2A (0.37) MMP12MMP13PLA2G2APLA2G4AHCRTR1
SCHEMBL21964849 0.94 PLA2G2A (0.37) MMP12MMP13PLA2G2APLA2G4AHCRTR1
SCHEMBL23318323 0.94 PLA2G2A (0.41) PLA2G2APLA2G4AAHRNPC1RAB9A
SCHEMBL21965095 0.94 MMP12 (0.39) MMP12MMP13PLA2G2APLA2G4AHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210135118-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2021-05-06 US disclosed
WO-2019009591-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 주식회사 두산 2019-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210135118-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ELAVL1, EML4, ELAVL3 MMP12 2785/4885MMP13 4191/4885PLA2G2A 3436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.